← Back to headlines

Herpes zoster more common with upadacitinib than adalimumab plus methotrexate in RA

This story is reported by Healio. Read what other outlets are saying below, then open the original report for full details.

Herpes zoster more common with upadacitinib than adalimumab plus methotrexate in RA · NabkaNews